Effect of calmodulin and calmodulin antagonists on the Ca2+ uptake by the intracellular Ca2+-accumulating system of guinea pig peritoneal macrophages treated with saponin

M. Hirata, E. Suematsu, T. Koga

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Guinea pig peritoneal macrophages were treated with saponin, and the effects of calmodulin and 'calmodulin antagonists' on the Ca2+ uptake of saponin-treated macrophages were examined. With this intracellular Ca2+-accumulating system we found that intact macrophages contained 672 ng/4 X 106 cells (2874 ng/mg of protein), which was reduced to 64 ng/4 X 106 cells (799 ng/mg of protein) by treatment of the macrophages with saponin. Exogeneously added calmodulin affected neither the maximal capacity of the Ca2+ uptake nor the apparent affinity of Ca2+ of the saponin-treated macrophages. All of the calmodulin antagonists examined [chlorpromazine, trifluoperazine, N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide, and N-(6-aminohexyl)-1-naphthalenesulfonamide] inhibited the Ca2+ uptake of saponin-treated macrophages. However, the concentrations of these drugs required for half-maximal inhibition of the Ca2+ uptake were much higher than those described for the calmodulin stimulation of phosphodiesterase. Troponin I, which inhibited calmodulin-stimulated phosphodiesterase activity, did not inhibit Ca2+ uptake. Inhibition of Ca2+ uptake by chlorpromazine and trifluoperazine was not reduced by the addition of excess calmodulin and was not altered by changes in concentration of both Mg-ATP and free Ca2+. The Ca2+ accumulated in saponin-treated macrophages was released by the addition of chlorpromazine and trifluoperazine, and, after removal of the drugs, Ca2+ accumulation was restored. This release of Ca2+ by chlorpromazine and trifluoperazine was concentration-dependent, and the concentration required for half-maximal release of Ca2+ was similar to that for half-maximal inhibition of Ca2+ uptake. From these findings, we conclude that the intracellular Ca2+-accumulating system in guinea pig peritoneal macrophages was not stimulated by calmodulin. Although calmodulin antagonists inhibited Ca2+ uptake and released accumulated Ca2+ in saponin-treated macrophages, these effects may be unrelated to the specific effect of the drugs on calmodulin.

Original languageEnglish
Pages (from-to)78-85
Number of pages8
JournalMolecular Pharmacology
Volume23
Issue number1
Publication statusPublished - Jan 1 1983

Fingerprint

Saponins
Peritoneal Macrophages
Calmodulin
Guinea Pigs
Macrophages
Trifluoperazine
Chlorpromazine
Type 1 Cyclic Nucleotide Phosphodiesterases
Pharmaceutical Preparations
Troponin I
Proteins
Adenosine Triphosphate

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Pharmacology

Cite this

Effect of calmodulin and calmodulin antagonists on the Ca2+ uptake by the intracellular Ca2+-accumulating system of guinea pig peritoneal macrophages treated with saponin. / Hirata, M.; Suematsu, E.; Koga, T.

In: Molecular Pharmacology, Vol. 23, No. 1, 01.01.1983, p. 78-85.

Research output: Contribution to journalArticle

@article{5c675a6e3ac143d48b2601c614d060f7,
title = "Effect of calmodulin and calmodulin antagonists on the Ca2+ uptake by the intracellular Ca2+-accumulating system of guinea pig peritoneal macrophages treated with saponin",
abstract = "Guinea pig peritoneal macrophages were treated with saponin, and the effects of calmodulin and 'calmodulin antagonists' on the Ca2+ uptake of saponin-treated macrophages were examined. With this intracellular Ca2+-accumulating system we found that intact macrophages contained 672 ng/4 X 106 cells (2874 ng/mg of protein), which was reduced to 64 ng/4 X 106 cells (799 ng/mg of protein) by treatment of the macrophages with saponin. Exogeneously added calmodulin affected neither the maximal capacity of the Ca2+ uptake nor the apparent affinity of Ca2+ of the saponin-treated macrophages. All of the calmodulin antagonists examined [chlorpromazine, trifluoperazine, N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide, and N-(6-aminohexyl)-1-naphthalenesulfonamide] inhibited the Ca2+ uptake of saponin-treated macrophages. However, the concentrations of these drugs required for half-maximal inhibition of the Ca2+ uptake were much higher than those described for the calmodulin stimulation of phosphodiesterase. Troponin I, which inhibited calmodulin-stimulated phosphodiesterase activity, did not inhibit Ca2+ uptake. Inhibition of Ca2+ uptake by chlorpromazine and trifluoperazine was not reduced by the addition of excess calmodulin and was not altered by changes in concentration of both Mg-ATP and free Ca2+. The Ca2+ accumulated in saponin-treated macrophages was released by the addition of chlorpromazine and trifluoperazine, and, after removal of the drugs, Ca2+ accumulation was restored. This release of Ca2+ by chlorpromazine and trifluoperazine was concentration-dependent, and the concentration required for half-maximal release of Ca2+ was similar to that for half-maximal inhibition of Ca2+ uptake. From these findings, we conclude that the intracellular Ca2+-accumulating system in guinea pig peritoneal macrophages was not stimulated by calmodulin. Although calmodulin antagonists inhibited Ca2+ uptake and released accumulated Ca2+ in saponin-treated macrophages, these effects may be unrelated to the specific effect of the drugs on calmodulin.",
author = "M. Hirata and E. Suematsu and T. Koga",
year = "1983",
month = "1",
day = "1",
language = "English",
volume = "23",
pages = "78--85",
journal = "Molecular Pharmacology",
issn = "0026-895X",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "1",

}

TY - JOUR

T1 - Effect of calmodulin and calmodulin antagonists on the Ca2+ uptake by the intracellular Ca2+-accumulating system of guinea pig peritoneal macrophages treated with saponin

AU - Hirata, M.

AU - Suematsu, E.

AU - Koga, T.

PY - 1983/1/1

Y1 - 1983/1/1

N2 - Guinea pig peritoneal macrophages were treated with saponin, and the effects of calmodulin and 'calmodulin antagonists' on the Ca2+ uptake of saponin-treated macrophages were examined. With this intracellular Ca2+-accumulating system we found that intact macrophages contained 672 ng/4 X 106 cells (2874 ng/mg of protein), which was reduced to 64 ng/4 X 106 cells (799 ng/mg of protein) by treatment of the macrophages with saponin. Exogeneously added calmodulin affected neither the maximal capacity of the Ca2+ uptake nor the apparent affinity of Ca2+ of the saponin-treated macrophages. All of the calmodulin antagonists examined [chlorpromazine, trifluoperazine, N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide, and N-(6-aminohexyl)-1-naphthalenesulfonamide] inhibited the Ca2+ uptake of saponin-treated macrophages. However, the concentrations of these drugs required for half-maximal inhibition of the Ca2+ uptake were much higher than those described for the calmodulin stimulation of phosphodiesterase. Troponin I, which inhibited calmodulin-stimulated phosphodiesterase activity, did not inhibit Ca2+ uptake. Inhibition of Ca2+ uptake by chlorpromazine and trifluoperazine was not reduced by the addition of excess calmodulin and was not altered by changes in concentration of both Mg-ATP and free Ca2+. The Ca2+ accumulated in saponin-treated macrophages was released by the addition of chlorpromazine and trifluoperazine, and, after removal of the drugs, Ca2+ accumulation was restored. This release of Ca2+ by chlorpromazine and trifluoperazine was concentration-dependent, and the concentration required for half-maximal release of Ca2+ was similar to that for half-maximal inhibition of Ca2+ uptake. From these findings, we conclude that the intracellular Ca2+-accumulating system in guinea pig peritoneal macrophages was not stimulated by calmodulin. Although calmodulin antagonists inhibited Ca2+ uptake and released accumulated Ca2+ in saponin-treated macrophages, these effects may be unrelated to the specific effect of the drugs on calmodulin.

AB - Guinea pig peritoneal macrophages were treated with saponin, and the effects of calmodulin and 'calmodulin antagonists' on the Ca2+ uptake of saponin-treated macrophages were examined. With this intracellular Ca2+-accumulating system we found that intact macrophages contained 672 ng/4 X 106 cells (2874 ng/mg of protein), which was reduced to 64 ng/4 X 106 cells (799 ng/mg of protein) by treatment of the macrophages with saponin. Exogeneously added calmodulin affected neither the maximal capacity of the Ca2+ uptake nor the apparent affinity of Ca2+ of the saponin-treated macrophages. All of the calmodulin antagonists examined [chlorpromazine, trifluoperazine, N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide, and N-(6-aminohexyl)-1-naphthalenesulfonamide] inhibited the Ca2+ uptake of saponin-treated macrophages. However, the concentrations of these drugs required for half-maximal inhibition of the Ca2+ uptake were much higher than those described for the calmodulin stimulation of phosphodiesterase. Troponin I, which inhibited calmodulin-stimulated phosphodiesterase activity, did not inhibit Ca2+ uptake. Inhibition of Ca2+ uptake by chlorpromazine and trifluoperazine was not reduced by the addition of excess calmodulin and was not altered by changes in concentration of both Mg-ATP and free Ca2+. The Ca2+ accumulated in saponin-treated macrophages was released by the addition of chlorpromazine and trifluoperazine, and, after removal of the drugs, Ca2+ accumulation was restored. This release of Ca2+ by chlorpromazine and trifluoperazine was concentration-dependent, and the concentration required for half-maximal release of Ca2+ was similar to that for half-maximal inhibition of Ca2+ uptake. From these findings, we conclude that the intracellular Ca2+-accumulating system in guinea pig peritoneal macrophages was not stimulated by calmodulin. Although calmodulin antagonists inhibited Ca2+ uptake and released accumulated Ca2+ in saponin-treated macrophages, these effects may be unrelated to the specific effect of the drugs on calmodulin.

UR - http://www.scopus.com/inward/record.url?scp=0020663479&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020663479&partnerID=8YFLogxK

M3 - Article

C2 - 6865902

AN - SCOPUS:0020663479

VL - 23

SP - 78

EP - 85

JO - Molecular Pharmacology

JF - Molecular Pharmacology

SN - 0026-895X

IS - 1

ER -